Core Viewpoint - Shuyou Shen (300204) experienced a significant decline in stock price, opening down 4.03% and dropping over 6% during trading, following the announcement of a major shareholder's plan to reduce their stake [1] Company Summary - Shuyou Shen announced that its major shareholder, Xiangtang Group Co., Ltd., intends to reduce its holdings by up to 4.7777 million shares, which represents 1% of the company's total share capital [1]

Core Viewpoint - The major shareholder, Xiangtang Group Co., Ltd., plans to reduce its stake in Shutaishen by selling up to 4.7777 million shares, which represents 1% of the company's total share capital, through block trading within three months after the announcement [2] Group 1 - Xiangtang Group holds 27.139608 million shares, accounting for 5.68% of the total share capital of Shutaishen [2] - The planned reduction of shares will occur 15 trading days after the announcement [2] - The maximum number of shares to be sold is 4.7777 million [2]

Core Points - The major shareholder of Shuotai Shen (300204), Xiangtang Group, plans to reduce its holdings by up to 4.7777 million shares, representing 1% of the company's total equity, within three months starting from 15 trading days after the announcement [1][1][1] - The reason for this reduction is cited as the group's own funding needs [1][1][1]

Group 1 - The core point of the article is that Xiangtang Group Limited, a shareholder holding 5.68% of Shutaishen (300204), has announced a reduction of its stake through a block trade, selling up to 4.7777 million shares, which represents 1% of the company's total share capital [1]

Core Viewpoint - The company Shuyou Shen (300204) announced that its shareholder, Xiangtang Group Co., Ltd., plans to reduce its holdings by up to 4.7777 million shares through block trading, which represents 1% of the company's total share capital [1] Summary by Category - **Shareholder Actions** - Xiangtang Group intends to reduce its stake in the company by a maximum of 4.7777 million shares [1] - The reduction will occur within three months after the announcement, starting 15 trading days from the date of disclosure [1] - **Impact on Company** - The planned reduction of shares may influence market perception and stock performance due to the decrease in shareholder confidence [1]

Core Viewpoint - The shareholder Xiangtang Group Limited plans to reduce its stake in Shutaishen (300204.SZ) by up to 4.7777 million shares, representing 1% of the company's total share capital, through block trading within three months after the announcement [1] Summary by Category - **Shareholder Action** - Xiangtang Group intends to sell up to 4.7777 million shares [1] - The planned reduction will occur within three months following the announcement [1] - The shares to be sold account for 1% of the total share capital of the company [1]

Group 1 - The major shareholder, Xiangtang Group Co., Ltd., plans to reduce its stake in Shutaishen (300204.SZ) by up to 4.7777 million shares, which represents 1% of the company's total share capital [1]

Group 1 - The core point of the article is that Xiangtang Group, a major shareholder of Shuyou Shen (SZ 300204), plans to reduce its holdings by up to 477.77 million shares, which is 1% of the company's total share capital, within three months after a 15 trading day period from the announcement date [1] - As of the announcement, Shuyou Shen's market capitalization is 17.8 billion yuan [2] - The company's revenue composition for the year 2024 is entirely from product sales, accounting for 100% [1]

舒泰神（北京）生物制药股份有限公司 关于持股 5%以上股东减持股份的预披露公告 特别提示： 证券代码：300204 证券简称：舒泰神 公告编号：2025-076 公司持股 5%以上股东香塘集团有限公司保证信息披露内容的真实、准确和 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 1、持舒泰神（北京）生物制药股份有限公司（以下简称"公司"或"舒泰 神"）股份 2,713.9608 万股（占公司总股本的 5.68%）的持股 5%以上股东香塘集 团有限公司（以下简称"香塘集团"）计划自本公告披露之日起 15 个交易日后的 3 个月内，以大宗交易方式减持股份不超过 477.77 万股，占公司总股本的 1%。 舒泰神于近日收到持股 5%以上股东香塘集团的股份减持计划告知函，现 将有关情况公告如下： 一、股东的基本情况 1、股东名称：香塘集团有限公司； 2、股东持股情况：截至本公告日，香塘集团持有公司股份 2,713.9608 万股， 占公司有表决权总股本的 5.68%，其中：持有有限售条件股份 0 股，持有无限售 条件股份 2,713.9608 万股。 二 ...

Core Viewpoint - The stock of Shuyou Shen experienced a decline of 2.02% on November 5, with a trading price of 37.28 CNY per share and a total market capitalization of 17.81 billion CNY. The company has seen significant fluctuations in its stock price throughout the year, with a year-to-date increase of 403.10% but a recent decline over the past 60 days of 25.56% [1]. Company Overview - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. was established on August 16, 2002, and went public on April 15, 2011. The company primarily engages in the research, production, and sales of biological products and some chemical drugs. Its main revenue sources include: 59.17% from injectable nerve growth factor (Sutai), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1][2]. Financial Performance - For the period from January to September 2025, Shuyou Shen reported an operating income of 181 million CNY, representing a year-on-year decrease of 30.82%. The net profit attributable to the parent company was -30.69 million CNY, a decline of 227.71% compared to the previous year [2][3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Shuyou Shen increased to 46,500, a rise of 46.97%. The average number of circulating shares per person decreased by 31.98% to 9,745 shares [2]. Dividend Distribution - Since its A-share listing, Shuyou Shen has distributed a total of 771 million CNY in dividends. However, there have been no dividend distributions in the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders as of September 30, 2025, Xingshan He Run Mixed A (163406) is the third-largest shareholder with 12.27 million shares, a decrease of 3.45 million shares from the previous period. Xingshan He Yi Mixed A (163417) is the fifth-largest with 9.34 million shares, an increase of 3.39 million shares. E Fund Healthcare Industry Mixed A (110023) remains the eighth-largest shareholder with 5.84 million shares unchanged from the previous period [3].